The global peptic ulcer testing market is projected to grow at the CAGR of 5.9% during the forecast period. The growth in the global peptic ulcer testing market is attributed to the development of advanced and new testing techniques such as Elisa tests, urea breath tests, stool tests, and other tests. New testing technique development is the core strength of major market players to have a competitive edge over their competitors. Moreover, as R&D for product development requires a huge capital expenditure the key players are rapidly adopting growth strategies such as mergers, acquisitions, collaboration, and partnerships to strengthen their revenue by increasing their market presence.
Browse
the full report description "Global Peptic Ulcer Testing Market Size, Share & Trends Analysis Report by Diagnostic tests (Endoscopy, Upper Gastrointestinal Series, and Laboratory Tests), and by End-User (Hospitals, Laboratories, and Others) Forecast Period (2022-2028)" at
In June 2018, Meridian Bioscience Inc. launched the Analyte Specific Reagent product range. The primary ASR products include a primer set and probes set for the detection of H. pylori and the target sequence associated with Clarithromycin-resistant H. pylori strains. Furthermore, in February 2017, Kibion launched Kibion Dynamic, an instrument based on the IRIS technology which is used for the quantitative diagnosis of breath tests. The kibion Dynamic employs detectors of a non-radioactive isotope based on infra-red technology. Kibion Dynamic along with Diabact UBT offers an end-to-end solution for the diagnosis of H. Pylori that is implicated in the peptic ulcer. The launch of these advanced and new testing techniques is anticipated to fuel the growth of global peptic ulcer testing market.
Moreover, companies are adopting strategic growth activities to expand the reach of their products. For instance, in June 2018, DiaSorin Inc. and Meridian Bioscience, Inc. had entered into a strategic collaboration to sell the DiaSorin’s FDA-cleared Helicobacter pylori stool antigen test for the detection of H. Pylori to make use of it on its automated LIASON platform under the brand name of Meridian across the globe. Besides, The Biohit healthcare had signed a distribution agreement with Accumed, an Irish pharmaceutical company that supplies diagnostic tests to the healthcare market of Northern and Southern Ireland. This agreement was signed by Biohit to increase its customer base in Ireland. These activities are further anticipated to drive the growth of the global peptic ulcer testing market.
Current market Trends covered in the Market Report
Global Peptic Ulcer Testing Market Segmentation
diagnostic Tests
By End-Users
Global Peptic Ulcer Testing Market – Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To
learn more about this report request a free sample copy @